应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
01167 加科思-B
未开盘 07-22 16:08:56
1.700
+0.020
+1.19%
最高
1.730
最低
1.660
成交量
8.82万
今开
1.680
昨收
1.680
日振幅
4.17%
总市值
13.42亿
流通市值
13.42亿
总股本
7.89亿
成交额
14.94万
换手率
0.01%
流通股本
7.89亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
加科思-B盘中异动 股价大跌5.08%报1.680港元
自选股智能写手 · 07-19
加科思-B盘中异动 股价大跌5.08%报1.680港元
加科思-B(01167)上涨8.05%,报1.88元/股
金融界 · 07-15
加科思-B(01167)上涨8.05%,报1.88元/股
加科思-B盘中异动 早盘股价大涨5.23%
自选股智能写手 · 07-15
加科思-B盘中异动 早盘股价大涨5.23%
加科思-B盘中异动 急速上涨5.49%
自选股智能写手 · 07-12
加科思-B盘中异动 急速上涨5.49%
加科思-B(01167)股价上升5.556%,现价港币$1.71
阿斯达克财经 · 07-12
加科思-B(01167)股价上升5.556%,现价港币$1.71
加科思-B(01167)上涨7.95%,报1.63元/股
金融界 · 07-11
加科思-B(01167)上涨7.95%,报1.63元/股
加科思-B盘中异动 急速拉升6.03%
自选股智能写手 · 07-11
加科思-B盘中异动 急速拉升6.03%
加科思-B盘中异动 快速上涨5.56%报1.520港元
自选股智能写手 · 07-10
加科思-B盘中异动 快速上涨5.56%报1.520港元
后PD-1时代重磅品种IND获受理 加科思(01167)驶向快车道
智通财经 · 07-10
后PD-1时代重磅品种IND获受理 加科思(01167)驶向快车道
加科思-B盘中异动 早盘股价大跌5.37%
自选股智能写手 · 07-05
加科思-B盘中异动 早盘股价大跌5.37%
加科思-B(01167)下跌5.77%,报1.47元/股
金融界 · 07-02
加科思-B(01167)下跌5.77%,报1.47元/股
加科思-B盘中异动 大幅下跌5.13%
自选股智能写手 · 07-02
加科思-B盘中异动 大幅下跌5.13%
格隆汇·中期策略峰会·2024金格奖之“ESG创新实践卓越企业”奖项揭晓:第四范式(06682.HK)、四环医药(00460.HK)等20家企业上榜
格隆汇 · 06-28
格隆汇·中期策略峰会·2024金格奖之“ESG创新实践卓越企业”奖项揭晓:第四范式(06682.HK)、四环医药(00460.HK)等20家企业上榜
加科思-B(01167)6月27日斥资25.06万港元回购16.35万股
智通财经网 · 06-27
加科思-B(01167)6月27日斥资25.06万港元回购16.35万股
加科思-B(01167)下跌5.63%,报1.51元/股
金融界 · 06-27
加科思-B(01167)下跌5.63%,报1.51元/股
加科思-B盘中异动 快速跳水5.06%
自选股智能写手 · 06-27
加科思-B盘中异动 快速跳水5.06%
加科思-B(01167)股价下跌5%,现价港币$1.52
阿斯达克财经 · 06-27
加科思-B(01167)股价下跌5%,现价港币$1.52
加科思-B(01167)6月26日斥资约22.3万港元回购13.95万股
智通财经网 · 06-26
加科思-B(01167)6月26日斥资约22.3万港元回购13.95万股
加科思-B(01167)6月25日耗资约24.86万港元回购15.54万股
智通财经 · 06-25
加科思-B(01167)6月25日耗资约24.86万港元回购15.54万股
加科思-B(01167)6月24日斥资25.6万港元回购16.05万股
智通财经 · 06-24
加科思-B(01167)6月24日斥资25.6万港元回购16.05万股
加载更多
公司概况
公司名称:
加科思-B
所属市场:
SEHK
上市日期:
--
主营业务:
加科思药业集团有限公司是一家主要从事临床阶段新药研发的中国投资控股公司。该公司主要负责创新肿瘤疗法的自主发现和开发。公司主要药物开发项目包括JAB-3068及JAB-3312临床阶段的变构SHP2抑制剂。该公司主要在国内市场开展业务。
发行价格:
--
{"stockData":{"symbol":"01167","market":"HK","secType":"STK","nameCN":"加科思-B","latestPrice":1.7,"timestamp":1721635736027,"preClose":1.68,"halted":0,"volume":88200,"delay":0,"floatShares":789419880,"shares":789419880,"eps":-0.49729022,"marketStatus":"未开盘","marketStatusCode":0,"change":0.02,"latestTime":"07-22 16:08:56","open":1.68,"high":1.73,"low":1.66,"amount":149436,"amplitude":0.041667,"askPrice":1.7,"askSize":2100,"bidPrice":1.66,"bidSize":11700,"shortable":0,"etf":0,"ttmEps":-0.49729022365092745,"exchange":"SEHK","tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1721698200000},"adr":0,"listingDate":1608480000000,"adjPreClose":1.68,"openAndCloseTimeList":[[1721611800000,1721620800000],[1721624400000,1721635200000]],"volumeRatio":0.165578,"lotSize":300,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/01167","defaultTab":"news","newsList":[{"id":"2452368446","title":"加科思-B盘中异动 股价大跌5.08%报1.680港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2452368446","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452368446?lang=zh_cn&edition=full","pubTime":"2024-07-19 15:46","pubTimestamp":1721375208,"startTime":"0","endTime":"0","summary":"2024年07月19日临近收盘15时46分,加科思-B股票出现波动,股价大幅下挫5.08%。截至发稿,该股报1.680港元/股,成交量25.56万股,换手率0.03%,振幅4.52%。资金方面,该股资金流入14.3154万港元,流出28.1952万港元。加科思-B股票所在的生物技术行业中,整体跌幅为0.71%。其相关个股中,创胜集团-B、泰格医药、友芝友生物-B涨幅较大,振幅较大的相关个股有华领医药-B、华康生物医学、锦欣生殖,振幅分别为20.00%、17.59%、14.09%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240719154648af931e13&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240719154648af931e13&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","01167","BK1574"],"gpt_icon":0},{"id":"2451650614","title":"加科思-B(01167)上涨8.05%,报1.88元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2451650614","media":"金融界","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451650614?lang=zh_cn&edition=full","pubTime":"2024-07-15 09:37","pubTimestamp":1721007470,"startTime":"0","endTime":"0","summary":"7月15日,加科思-B(01167)盘中上涨8.05%,截至09:37,报1.88元/股,成交106.02万元。加科思药业集团有限公司是一家专注于临床阶段新药研发,特别是创新肿瘤疗法的自主发现和开发的中国投资控股公司。其主要药物开发项目包括JAB-3068及JAB-3312临床阶段的变构SHP2抑制剂,并主要在国内市场开展业务。截至2023年年报,加科思-B营业总收入6352.0万元、净利润-3.59亿元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/07/15093741565419.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1574","BK1161","01167"],"gpt_icon":0},{"id":"2451966830","title":"加科思-B盘中异动 早盘股价大涨5.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2451966830","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451966830?lang=zh_cn&edition=full","pubTime":"2024-07-15 09:31","pubTimestamp":1721007074,"startTime":"0","endTime":"0","summary":"2024年07月15日早盘09时31分,加科思-B股票出现异动,股价快速拉升5.23%。截至发稿,该股报1.831港元/股,成交量20.31万股,换手率0.03%,振幅4.60%。加科思-B股票所在的生物技术行业中,整体跌幅为0.16%。其相关个股中,金斯瑞生物科技、加科思-B、康希诺生物涨幅较大,振幅较大的相关个股有金斯瑞生物科技、来凯医药-B、加科思-B,振幅分别为17.80%、5.01%、4.60%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407150931149681c8ce&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407150931149681c8ce&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","01167","BK1161"],"gpt_icon":0},{"id":"2450532436","title":"加科思-B盘中异动 急速上涨5.49%","url":"https://stock-news.laohu8.com/highlight/detail?id=2450532436","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450532436?lang=zh_cn&edition=full","pubTime":"2024-07-12 11:56","pubTimestamp":1720756580,"startTime":"0","endTime":"0","summary":"2024年07月12日临近午盘11时56分,加科思-B股票出现异动,股价快速拉升5.49%。截至发稿,该股报1.710港元/股,成交量39.18万股,换手率0.05%,振幅7.41%。加科思-B股票所在的生物技术行业中,整体涨幅为1.40%。其相关个股中,科伦博泰生物-B、康诺亚-B、圣诺医药-B涨幅较大,振幅较大的相关个股有圣诺医药-B、科伦博泰生物-B、乐普生物-B,振幅分别为13.10%、11.95%、10.67%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407121156209681c42c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407121156209681c42c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","01167","BK1161"],"gpt_icon":0},{"id":"2450248463","title":"加科思-B(01167)股价上升5.556%,现价港币$1.71","url":"https://stock-news.laohu8.com/highlight/detail?id=2450248463","media":"阿斯达克财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450248463?lang=zh_cn&edition=full","pubTime":"2024-07-12 11:56","pubTimestamp":1720756560,"startTime":"0","endTime":"0","summary":"[上升股]加科思-B(01167) 股价在上午11:56比前收市价上升5.556%,现股价为港币$1.71。至目前为止,今日最高价为$1.71,而最低价为$1.59。总成交量为38.97万股,总成交金额为港币$65.31万。","market":"sh","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180205152549604_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180205152549604_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2407123187/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["01167","BK1161","BK1574"],"gpt_icon":0},{"id":"2450538773","title":"加科思-B(01167)上涨7.95%,报1.63元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2450538773","media":"金融界","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450538773?lang=zh_cn&edition=full","pubTime":"2024-07-11 15:53","pubTimestamp":1720684391,"startTime":"0","endTime":"0","summary":"7月11日,加科思-B(01167)盘中上涨7.95%,截至15:53,报1.63元/股,成交100.69万元。加科思药业集团有限公司是一家专注于临床阶段新药研发,特别是创新肿瘤疗法的自主发现和开发的中国投资控股公司。其主要药物开发项目包括JAB-3068及JAB-3312临床阶段的变构SHP2抑制剂,并主要在国内市场开展业务。截至2023年年报,加科思-B营业总收入6352.0万元、净利润-3.59亿元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/07/11155341510594.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1161","01167","BK1574"],"gpt_icon":0},{"id":"2450874442","title":"加科思-B盘中异动 急速拉升6.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2450874442","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450874442?lang=zh_cn&edition=full","pubTime":"2024-07-11 09:51","pubTimestamp":1720662712,"startTime":"0","endTime":"0","summary":"2024年07月11日早盘09时51分,加科思-B股票出现异动,股价急速上涨6.03%。截至发稿,该股报1.601港元/股,成交量14.04万股,换手率0.02%,振幅5.96%。机构评级方面,在所有1家参与评级的机构中,100%的券商给予买入建议,无券商给予持有、卖出建议。加科思-B股票所在的生物技术行业中,整体涨幅为0.78%。其相关个股中,盛禾生物-B、昭衍新药、荣昌生物涨幅较大,振幅较大的相关个股有科伦博泰生物-B、圣诺医药-B、昭衍新药,振幅分别为16.80%、9.48%、6.95%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240711095152941f6018&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240711095152941f6018&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1574","01167"],"gpt_icon":0},{"id":"2450383392","title":"加科思-B盘中异动 快速上涨5.56%报1.520港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2450383392","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450383392?lang=zh_cn&edition=full","pubTime":"2024-07-10 11:12","pubTimestamp":1720581152,"startTime":"0","endTime":"0","summary":"2024年07月10日早盘11时12分,加科思-B股票出现异动,股价急速拉升5.56%。截至发稿,该股报1.520港元/股,成交量20.31万股,换手率0.03%,振幅4.86%。资金方面,该股资金流入21.5385万港元,流出8.6394万港元。加科思-B股票所在的生物技术行业中,整体跌幅为0.27%。其相关个股中,嘉和生物-B、加科思-B、绿竹生物-B涨幅较大,振幅较大的相关个股有永泰生物-B、宜明昂科-B、圣诺医药-B,振幅分别为20.19%、10.24%、8.55%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240710111232af917dac&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240710111232af917dac&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","01167","BK1161"],"gpt_icon":0},{"id":"2450854258","title":"后PD-1时代重磅品种IND获受理 加科思(01167)驶向快车道","url":"https://stock-news.laohu8.com/highlight/detail?id=2450854258","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450854258?lang=zh_cn&edition=full","pubTime":"2024-07-10 08:49","pubTimestamp":1720572585,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,7月10日,国家药品监督管理局药品审评中心网站显示加科思的泛KRAS抑制剂JAB-23E73的新药临床试验申请已获受理,该产品是目前全球进度第一的口服广谱KRAS抑制剂。在核心管线方面,加科思已经在5月递交了KRAS G12C抑制剂glecirasib的二线非小细胞肺癌适应症新药上市申请,即将为公司首次带来商业化收入。加科思还拥有全球唯一进入注册性临床阶段的SHP2抑制剂JAB-3312,计划通过联合用药成为全球一线疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1148341.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01167","BK4023","LU1169590202.USD","LU1169589451.USD","PD","BK1574","BK1161"],"gpt_icon":0},{"id":"2449288769","title":"加科思-B盘中异动 早盘股价大跌5.37%","url":"https://stock-news.laohu8.com/highlight/detail?id=2449288769","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2449288769?lang=zh_cn&edition=full","pubTime":"2024-07-05 09:44","pubTimestamp":1720143895,"startTime":"0","endTime":"0","summary":"2024年07月05日早盘09时44分,加科思-B股票出现波动,股价快速下跌5.37%。截至发稿,该股报1.410港元/股,成交量1.77万股,换手率0.00%,振幅3.36%。资金方面,该股资金流入0港元,流出2.5755万港元。加科思-B股票所在的生物技术行业中,整体跌幅为0.01%。其相关个股中,东曜药业-B、美因基因、基石药业-B涨幅较大,振幅较大的相关个股有科笛-B、来凯医药-B、基石药业-B,振幅分别为8.51%、6.44%、5.17%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024070509445596819b5f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024070509445596819b5f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1161","01167"],"gpt_icon":0},{"id":"2448818961","title":"加科思-B(01167)下跌5.77%,报1.47元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2448818961","media":"金融界","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448818961?lang=zh_cn&edition=full","pubTime":"2024-07-02 15:54","pubTimestamp":1719906884,"startTime":"0","endTime":"0","summary":"7月2日,加科思-B(01167)盘中下跌5.77%,截至15:54,报1.47元/股,成交102.32万元。加科思药业集团有限公司是一家专注于临床阶段新药研发,特别是创新肿瘤疗法的自主发现和开发的中国投资控股公司。其主要药物开发项目包括JAB-3068及JAB-3312临床阶段的变构SHP2抑制剂,并主要在国内市场开展业务。截至2023年年报,加科思-B营业总收入6352.0万元、净利润-3.59亿元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/07/02155441321052.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1574","01167","BK1161"],"gpt_icon":0},{"id":"2448043729","title":"加科思-B盘中异动 大幅下跌5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2448043729","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2448043729?lang=zh_cn&edition=full","pubTime":"2024-07-02 13:21","pubTimestamp":1719897663,"startTime":"0","endTime":"0","summary":"2024年07月02日下午盘13时21分,加科思-B股票出现波动,股价快速跳水5.13%。截至发稿,该股报1.480港元/股,成交量28.05万股,换手率0.04%,振幅5.77%。加科思-B股票所在的生物技术行业中,整体跌幅为1.05%。其相关个股中,歌礼制药-B、正大企业国际、诺诚健华涨幅较大,振幅较大的相关个股有帝王国际投资、东曜药业-B、正大企业国际,振幅分别为14.06%、13.24%、11.69%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240702132103aef7821f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240702132103aef7821f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","01167","BK1161"],"gpt_icon":0},{"id":"2446523202","title":"格隆汇·中期策略峰会·2024金格奖之“ESG创新实践卓越企业”奖项揭晓:第四范式(06682.HK)、四环医药(00460.HK)等20家企业上榜","url":"https://stock-news.laohu8.com/highlight/detail?id=2446523202","media":"格隆汇","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446523202?lang=zh_cn&edition=full","pubTime":"2024-06-28 14:33","pubTimestamp":1719556395,"startTime":"0","endTime":"0","summary":"奖项的获奖企业,以其创新精神和实践,展现了在ESG领域的领导力和开拓性。","market":"us","thumbnail":"https://img3.gelonghui.com/da638-11370621-7d57-4f05-9f2f-6192656e7902.jpg?guru_height=930&guru_width=1405","type":0,"news_type":0,"thumbnails":["https://img3.gelonghui.com/da638-11370621-7d57-4f05-9f2f-6192656e7902.jpg?guru_height=930&guru_width=1405"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/819481","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["BK1593","02302","03611","BK1109","09880","06609","BK1515","BK0231","BK1152","03773","BK1128","00460","01167","ESG","BK1161","BK1183","BK1228","SG9999001069.SGD","BK1595","02438","09959","BK1191","02391","00382","01725","BK1100","BK1124","BK1574","06682","BK1600","BK1516","01969","BK1117","02265","01675","688031","BK1167","BK1556","BK1140","BK1575","BK1587","BK1518","BK1142"],"gpt_icon":0},{"id":"2446539724","title":"加科思-B(01167)6月27日斥资25.06万港元回购16.35万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2446539724","media":"智通财经网","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446539724?lang=zh_cn&edition=full","pubTime":"2024-06-27 20:13","pubTimestamp":1719490394,"startTime":"0","endTime":"0","summary":"智通财经APP讯,加科思-B(01167)发布公告,于2024年6月27日该公司斥资25.06万港元回购16.35万股,回购价格为每股1.51-1.53港元。更多港股重磅资讯,下载智通财经app更多港股及海外理财资讯,请点击www.zhitongcaijing.com(搜索“智通财经”);欲加入智通港股投资群,请加智通客服微信(ztcjkf)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1141867.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK1161","BK1574","01167"],"gpt_icon":0},{"id":"2446308182","title":"加科思-B(01167)下跌5.63%,报1.51元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2446308182","media":"金融界","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446308182?lang=zh_cn&edition=full","pubTime":"2024-06-27 13:55","pubTimestamp":1719467705,"startTime":"0","endTime":"0","summary":"6月27日,加科思-B(01167)盘中下跌5.63%,截至13:55,报1.51元/股,成交101.01万元。加科思药业集团有限公司是一家专注于临床阶段新药研发,特别是创新肿瘤疗法的自主发现和开发的中国投资控股公司。其主要药物开发项目包括JAB-3068及JAB-3312临床阶段的变构SHP2抑制剂,并主要在国内市场开展业务。截至2023年年报,加科思-B营业总收入6352.0万元、净利润-3.59亿元。6月26日,公司以每股1.58-1.63港元回购13.95万股,回购金额22.3万港元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/06/27135541231491.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1574","BK1161","01167"],"gpt_icon":0},{"id":"2446508371","title":"加科思-B盘中异动 快速跳水5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2446508371","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446508371?lang=zh_cn&edition=full","pubTime":"2024-06-27 11:57","pubTimestamp":1719460675,"startTime":"0","endTime":"0","summary":"2024年06月27日临近午盘11时57分,加科思-B股票出现异动,股价快速跳水5.06%。截至发稿,该股报1.520港元/股,成交量37.17万股,换手率0.05%,振幅3.75%。加科思-B股票所在的生物技术行业中,整体跌幅为1.58%。其相关个股中,创胜集团-B、永泰生物-B、盛禾生物-B涨幅较大,振幅较大的相关个股有歌礼制药-B、帝王国际投资、方达控股,振幅分别为15.29%、13.33%、12.05%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240627115755af8f7141&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240627115755af8f7141&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01167","BK1574","BK1161"],"gpt_icon":0},{"id":"2446710603","title":"加科思-B(01167)股价下跌5%,现价港币$1.52","url":"https://stock-news.laohu8.com/highlight/detail?id=2446710603","media":"阿斯达克财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446710603?lang=zh_cn&edition=full","pubTime":"2024-06-27 11:57","pubTimestamp":1719460620,"startTime":"0","endTime":"0","summary":"[下跌股]加科思-B(01167) 股价在上午11:57比前收市价下跌5%,现股价为港币$1.52。至目前为止,今日最高价为$1.58,而最低价为$1.52。总成交量为37.17万股,总成交金额为港币$57.774万。","market":"sh","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180126135515084_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180126135515084_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2406272793/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1574","BK1161","01167"],"gpt_icon":0},{"id":"2446615443","title":"加科思-B(01167)6月26日斥资约22.3万港元回购13.95万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2446615443","media":"智通财经网","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446615443?lang=zh_cn&edition=full","pubTime":"2024-06-26 19:32","pubTimestamp":1719401548,"startTime":"0","endTime":"0","summary":"加科思-B(01167)发布公告,于2024年6月26日斥资约22.3万港元回购股...","market":"hk","thumbnail":"https://img.zhitongcaijing.com/gonggao/ztcj_announce_28.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/gonggao/ztcj_announce_28.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1141030.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK1161","BK1574","01167"],"gpt_icon":0},{"id":"2446786816","title":"加科思-B(01167)6月25日耗资约24.86万港元回购15.54万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2446786816","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446786816?lang=zh_cn&edition=full","pubTime":"2024-06-25 18:55","pubTimestamp":1719312931,"startTime":"0","endTime":"0","summary":"智通财经APP讯,加科思-B(01167)公布,2024年6月25日耗资约24.86万港元回购15.54万股股份。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1140246.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01167","BK1161","BK1574"],"gpt_icon":0},{"id":"2445702445","title":"加科思-B(01167)6月24日斥资25.6万港元回购16.05万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2445702445","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2445702445?lang=zh_cn&edition=full","pubTime":"2024-06-24 18:45","pubTimestamp":1719225911,"startTime":"0","endTime":"0","summary":"智通财经APP讯,加科思-B(01167)发布公告,于2024年6月24日斥资25.6万港元回购16.05万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1139576.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01167","BK1574","BK1161"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.jacobiopharma.com","stockEarnings":[{"period":"1week","weight":-0.0449},{"period":"1month","weight":0.0429},{"period":"3month","weight":0.1644},{"period":"6month","weight":-0.4158},{"period":"1year","weight":-0.5596},{"period":"ytd","weight":-0.5304}],"compareEarnings":[{"period":"1week","weight":-0.0211},{"period":"1month","weight":-0.0218},{"period":"3month","weight":0.048},{"period":"6month","weight":0.1092},{"period":"1year","weight":-0.0755},{"period":"ytd","weight":0.0345}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"加科思药业集团有限公司是一家主要从事临床阶段新药研发的中国投资控股公司。该公司主要负责创新肿瘤疗法的自主发现和开发。公司主要药物开发项目包括JAB-3068及JAB-3312临床阶段的变构SHP2抑制剂。该公司主要在国内市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.005532},{"month":2,"riseRate":0.25,"avgChangeRate":0.053851},{"month":3,"riseRate":0,"avgChangeRate":-0.187604},{"month":4,"riseRate":0.75,"avgChangeRate":0.048427},{"month":5,"riseRate":0.25,"avgChangeRate":-0.044098},{"month":6,"riseRate":0,"avgChangeRate":-0.038854},{"month":7,"riseRate":0.25,"avgChangeRate":-0.140523},{"month":8,"riseRate":0.333333,"avgChangeRate":0.025412},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.12321},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.013633},{"month":11,"riseRate":0.333333,"avgChangeRate":0.071626},{"month":12,"riseRate":0.333333,"avgChangeRate":0.002401}],"exchange":"SEHK","name":"加科思-B","nameEN":"JACOBIO-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"加科思-B(01167)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供加科思-B(01167)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"加科思-B,01167,加科思-B股票,加科思-B股票老虎,加科思-B股票老虎国际,加科思-B行情,加科思-B股票行情,加科思-B股价,加科思-B股市,加科思-B股票价格,加科思-B股票交易,加科思-B股票购买,加科思-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"加科思-B(01167)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供加科思-B(01167)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}